| Literature DB >> 25492866 |
Wenke Seifert1, Jirko Kühnisch2, Tanja Maritzen3, Stefanie Lommatzsch4, Hans Christian Hennies5, Sebastian Bachmann4, Denise Horn6, Volker Haucke3.
Abstract
Postnatal microcephaly, intellectual disability, and progressive retinal dystrophy are major features of autosomal recessive Cohen syndrome, which is caused by mutations in the gene COH1 (VPS13B). We have recently identified COH1 as a Golgi-enriched scaffold protein that contributes to the structural maintenance and function of the Golgi complex. Here, we show that association of COH1 with the Golgi complex depends on the small GTPase RAB6. RNAi-mediated knockdown of RAB6A/A' prevents the localization of COH1 to the Golgi complex. Expression of the constitutively inactive RAB6_T27N mutant led to an increased solubilization of COH1 from lipid membrane preparations. Co-IP experiments confirmed the physical interaction of COH1 with RAB6 that preferentially occurred with the constitutively active RAB6_Q72L mutants. Depletion of COH1 in primary neurons negatively interfered with neurite outgrowth, indicating a causal link between the integrity of the Golgi complex and axonal outgrowth. We conclude that COH1 is a RAB6 effector protein and that reduced brain size in Cohen syndrome patients likely results from impaired COH1 function at the Golgi complex, causing decreased neuritogenesis.Entities:
Keywords: COH1; Cohen Syndrome; GTPase; Genetic Disease; Golgi; Neurite Outgrowth; Protein-Protein Interaction; RAB6
Mesh:
Substances:
Year: 2014 PMID: 25492866 PMCID: PMC4319006 DOI: 10.1074/jbc.M114.608174
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157